NCT03644875View on ClinicalTrials.gov

Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber

CompletedOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

May 16, 2019

Study Completion Date

May 16, 2019

Conditions

Cataract Surgery

Interventions

DEVICE

etacoat

Etacoat is a HPMC formulation intended to be used in ophthalmic anterior segment cataract surgery.

Trial Locations (1)

Unknown

Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital, Vienna

Sponsors

Lead Sponsor

Croma-Pharma GmbH

All Listed Sponsors

lead

Croma-Pharma GmbH

INDUSTRY

NCT03644875 - Study of Etacoat in Patients With Cataract Surgery Via the Anterior Chamber | Biotech Hunter | Biotech Hunter